Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate

Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate

US Patent 11266620 · Granted Mar 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of pyroptosis2023
Treatment of necroptosis2023
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists2020
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treati2020
Treatment of diseases associated with hepatic stellate cell activation using amm2020
Treatment of diseases associated with hepatic stellate cell activation using amm2018
Treating renal and liver dysfunction with TLR4 antagonists2018
Porous carbon particles for use in the treatment or prevention of liver disease2017
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treati2017
Therapy for liver disease2013
Biomarkers for assessing liver function2013